Intrinsic Therapeutics

Woburn, United States Founded: 2000 • Age: 26 yrs
Spinal disc reconstruction prostheses are developed to prevent reherniation.

About Intrinsic Therapeutics

Intrinsic Therapeutics is a Healthcare company based in Woburn (United States) founded in 2000. Spinal disc reconstruction prostheses are developed to prevent reherniation. Intrinsic Therapeutics has raised $138.68 million across 8 funding rounds from investors including Credit Suisse, Greenspring Associates and CRG. Its chief executive, as recorded, is Cary Hagan. Intrinsic Therapeutics offers products and services including Barricaid Implant. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is Authentidate Holding Corp. Its competitors include Nevro, ATEC Spine and Vertos Medical; 2 of its 3 listed competitors have raised funding.

Company details

Intrinsic Therapeutics was founded in 2000 and is based in Woburn, United States. Operations focus on the medical device sector, where implantable prostheses for spinal annulus repair are produced. The Barricaid device is designed for use after limited discectomy to reinforce annular defects and lower reherniation risks. This addresses weaknesses created by nuclear material removal during surgery for disc herniation.

Operational Areas
Key Metrics
  • Total Equity Funding
    $138.68M (USD)

    in 8 rounds

  • Latest Funding Round
    $28M (USD), Series D

    May 2017

  • Investors

Products & Services of Intrinsic Therapeutics

Intrinsic Therapeutics offers a comprehensive portfolio of products and services, including Barricaid Implant.

Barricaid Implant
Medical Device

Implant reduces reherniation risk after discectomy surgery

Apps and channels of Intrinsic Therapeutics

its YouTube channel Barricaid® has 409 subscribers and 30 videos.

Barricaid®
YouTube 409 subscribers 30 videos Science & Technology
Open channel

Videos from Intrinsic Therapeutics

The most watched videos on Intrinsic Therapeutics's YouTube channel, Barricaid® (409 subscribers). Click a video to play it here.

Barricaid – A Climber’s Route to Recovery
965.4K views
Barricaid – A Fitness Instructor’s Story
449.4K views
What happens when a discectomy fails? Melanie's Story
201.1K views
What happens when a discectomy fails? Maria's Story
94.3K views

More on Barricaid®.

Funding Insights of Intrinsic Therapeutics

Intrinsic Therapeutics has successfully raised a total of $138.68M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $28 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $138.68M
  • Total Rounds 8
  • Last Round Series D — $28M
  • First Round $25M

    (Jan 2003)

  • Investors Count 7

All 8 funding rounds of Intrinsic Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2017$28MSeries D–New Enterprise Associates
May 2017$21MDebt – Venture––
Dec 2016$17.88MSeries C––
–
Sep 2014$17.2MSeries C––
–
Oct 2012$11.6MSeries C––
–
Feb 2010$18MSeries C––
–
Sep 2007$21MSeries C––
Jan 2003$25MSeries C––
Valuation history

7 investors in total: 7 institutional.

Investors in Intrinsic Therapeutics

Intrinsic Therapeutics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Credit Suisse, Greenspring Associates and CRG.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
CRG is recognized as a premier healthcare investment partner.
crglp.comHouston, United States
Venture capital investments are offered to startups by NEA.
nea.comMenlo Park, United States
Diversified investment management firm
2000greenspringassociates.comOwings Mills, United States
Sector-agnostic investment company making venture capital investments globally
quadrillecapital.comParis, France
Venture capital investments are directed toward therapeutics and medtech startups.
deloscapital.comHong Kong, China
spraypartners.com
Wealth management, asset management, and investment banking services are offered.
1856credit-suisse.comZurich, Switzerland
Premium access

Investor details for Intrinsic Therapeutics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Intrinsic Therapeutics

1 people are tracked at Intrinsic Therapeutics (1 in leadership).

NameRoleGroup
Cary Hagan
CEO & PresidentLeadership
Premium access

Complete people profiles for Intrinsic Therapeutics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Intrinsic Therapeutics

3 dated milestones of Intrinsic Therapeutics across 17 years, from founding to its latest funding, stage changes and deals.

  1. Founded Intrinsic Therapeutics is founded.
  2. Funding First funding round of $25.0M.
  3. Funding Latest funding round, Series D, of $28.0M.

Competitors of Intrinsic Therapeutics

Intrinsic Therapeutics has 3 listed competitors in our database, 2 of them funded. They include Nevro, ATEC Spine and Vertos Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
nevro.com2006Menlo Park, United States$154.1M1,215
Provider of high-frequency spinal cord stimulation implants
atecspine.com1990San Diego, United States839
Treatment solutions for spine disorders are developed.
vertosmed.com2005Aliso Viejo, United States$177.75M140
Minimally invasive treatments for lumbar spinal stenosis are developed.
Premium access

Detailed competitors of Intrinsic Therapeutics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Orthopedics

3 companies that operate in the same segment as Intrinsic Therapeutics (Orthopedics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of high-frequency spinal cord stimulation implants
2006Menlo Park, California, United StatesUSD 154.1 MUSD 353.08 M1,215
Developer of therapies for the treatment of musculoskeletal disorders
2007Woburn, Massachusetts, United StatesUSD 62 MUSD 85.55 M692
Antibody-siRNA complexes are developed for cancer treatment.
2012San Diego, California, United StatesUSD 142.54 MUSD 10.9 M391
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Intrinsic Therapeutics

Intrinsic Raises $21 Million - PE Hub
Pehub • 19 years ago
Premium access

Complete news archive for Intrinsic Therapeutics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Intrinsic Therapeutics

Intrinsic Therapeutics was founded in 2000 and raised its 1st funding round 3 years after it was founded.

Intrinsic Therapeutics is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.

Cary Hagan is the CEO of Intrinsic Therapeutics, as recorded in our data.

Intrinsic Therapeutics is a funded company, having raised a total of $138.68M across 8 funding rounds to date. The company's 1st funding round was a Series C of $25M, raised on Jan 2003.

Intrinsic Therapeutics was founded in 2000 and is based in Woburn, United States. Operations focus on the medical device sector, where implantable prostheses for spinal annulus repair are produced. The Barricaid device is designed for use after limited discectomy to reinforce annular defects and lower reherniation risks. This addresses weaknesses created by nuclear material removal during surgery for disc herniation.

Intrinsic Therapeutics's top competitors include Nevro, ATEC Spine and Vertos Medical.

Intrinsic Therapeutics offers Barricaid Implant.

Intrinsic Therapeutics has 7 investors. Key investors include Credit Suisse, Greenspring Associates, CRG, NEA, and Quadrille Capital.

Intrinsic Therapeutics operates through Authentidate Holding Corp.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available